#pharmaceuticals

#pharmaceuticals

Coartem Baby, developed by Medicines for Malaria Venture and Novartis, is the first malaria drug approved for infants and those weighing under 11 pounds.

We would never suggest that investors base their investing decisions solely on insider buying... So, it's just best to do your research first.

The researchers discovered that by guiding living Escherichia coli bacteria, they could trigger natural processes to transform waste into valuable medicinal compounds like paracetamol.

The current approach to manufacturing compounded medications is outdated and poorly optimised - failing both pharmacies and the patients they serve. Even with highly trained pharmacists and modern equipment, the process remains unnecessarily labour-intensive, prone to human error, and inconsistent in quality.

The FTC's recent letter campaign could result in prolonged litigation beyond Hatch-Waxman timelines, impacting patent validity and consumer access to generics.

Ono Pharma USA is set to lay off 83 employees by June 30, reflecting a broader trend among biotech companies in the state.

AstraZeneca faces protests over executive pay while grappling with serious investigations in China, overshadowing its significant financial success due to strong treatment sales.

The Federal Circuit confirmed that Mylan's generic label in its ANDA could lead to induced infringement of Janssen's antipsychotic patents, emphasizing label intent.